San Diego’s Heron Therapeutics Inc. plans to raise $150 million in a public offering of its common stock.
San Diego biotech AnaptysBio has set the price of its initial public offering, expecting to raise about $60 million from the sale of its common stock.
Local test maker Banyan Biomarkers is partnering with bioMerieux, a French giant in biotechnology, to develop a blood test that would identify traumatic brain injury.
Shares of locally based DexCom Inc. have soared this month following news that patients will have easier access to the medical device maker’s main product.
Ryan Mickle, a local startup CEO, has launched a website to help fellow entrepreneurs wade through stacks of referrals.
Local cell therapy company Cytori Therapeutics Inc. is acquiring San Antonio-based Azaya Therapeutics for up to $170 million.
TECH: Course Correction Put Marketing Company In Pursuit of New Verticals
Anyone who has walked past Underground Elephant’s new downtown digs knows that the adtech firm is anything but underground.
U.S. oil giant Exxon Mobil Corp. has renewed a deal with local biotech Synthetic Genomics Inc. to jointly research algae biofuels.
Shares of drugmaker aTyr Pharma climbed over 30 percent Wednesday following news that the San Diego firm’s drug should progress quickly through the regulatory process.
Depression and stress don’t often come up in gatherings of young entrepreneurs, but the topic struck a chord at Startup Grind’s first meeting of the year.